Professor Gurmit Singh
Position:
- Professor, Pathology and Molecular Medicine, McMaster University
- Senior Scientist, Hamilton Health Sciences
Websites:
Biography:
Dr Gurmit Singh is Professor of Pathology and Molecular Medicine at McMaster University in Hamilton. His research interests include experimental therapeutics in breast and prostate cancer, with an emphasis in bone metastasis. He serves on a number of national and international scientific review panels that include CIHR, NCIC, CFI, and the U.S. Army and Navel panels. In addition, he is an external grant reviewer for several research foundations and belongs to many associations including the American Association for Cancer Research, American Association for the Advancement of Science and the Metastasis Research Society. He also serves on the editorial board of several scientific journals.
He is currently working on a number of research projects including “Cancer Induced Bone Pain” with funding received from the Canadian breast Cancer Research Alliance, “Reactive oxygen species: A link between hyperglycemia and cancer” with funding from the Canadian Institutes of Health (CIHR) ; “Role of Glutamate in bone Metastasis” with Funding from Canadian Institutes of Health Research (CIHR); “Mitochondria as a target for Cancer Therapy” with funding from Canadian Institutes of Health Research (CIHR) and other projects with an emphasis on experimental therapeutics. He has edited three books and published over 170 research articles.
behaviour, bony metastasis, cancer progression, exogenous factors, marker discovery, metastases, model systems, systemic therapies, technology development, therapeutics, reactive oxygen species, pain.
